GGrantIndex
Sort

141,003 grants matching cytokine

Immunity to Pneumonic Tularemia

$752,408
Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics

$752,287
Fernando Holguin · University Of Colorado Denver · R33 · FY2024 · HL

Impact of illicit drugs, HIV, and ART on neuroinflammation and BBB disruption

$752,263
Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2021 · DA

T cells in the aging brain

$752,242
Anne Brunet · Stanford University · R01 · FY2021 · AG

Functions of IL-17 Family Cytokines and their Signaling Mechanisms in Health and Disease

$752,240
Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Controlled Infection Trial to Test Efficacy of Hookworm Vaccine with Different TLR Agonists

$752,220
David Joseph Diemert · George Washington University · U01 · FY2019 · AI

Blood Base Bioenergetic Profiling: A Novel Approach for Identifying Alzheimer's Disease Risk and Pathology

$752,198
Barbara J Nicklas · Wake Forest University Health Sciences · R01 · FY2020 · AG

Maternal Stress and the Gut-Brain Axis in African American Infants

$752,160
Elizabeth J Corwin · Emory University · R01 · FY2016 · MD

Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses

$752,147
Kamal Mohan Khanna · New York University School Of Medicine · R01 · FY2025 · DK

DIETS FOR DYSLIPIDEMIA IN THE METABOLIC SYNDROME

$752,145
Robert Henry Knopp · University Of Washington · R01 · FY2007 · HL

Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease

$752,131
Elizabeth Head · University Of California-Irvine · R01 · FY2019 · AG

The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)

$752,119
Nicholas T. Funderburg · Ohio State University · U01 · FY2024 · AI

The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis

$752,082
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA

Proteogenomics of dysregulated protein interaction networks in MTB infection

$752,076
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2010 · HL

Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome

$752,030
Christopher J Lessard · Oklahoma Medical Research Foundation · R01 · FY2023 · AR

Linking Antibody Cooperativity and Effector Cell Engagement

$751,989
Guido Ferrari · Duke University · P01 · FY2021 · AI

Novel RORgamma antagonists for inflammation and autoimmune disease

$751,968
F Javier Piedrafita · Torrey Pines Inst For Molecular Studies · R01 · FY2014 · AI

Attenuating Inflammation to Restore GI Tract Integrity and Reduce Viral Reservoirs During cART

$751,962
Jacob D Estes · Oregon Health & Science University · R01 · FY2022 · DK

Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms

$751,951
Richard P Sloan · Columbia University Health Sciences · R01 · FY2012 · HL

Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans

$751,928
Ivan Zanoni · Boston Children'S Hospital · R01 · FY2022 · AI

The Role Of Innate Immunity Genes In Viral Infection and Disease Progression

$751,925
Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

Basic and clinical studies in immune function and metabolism

$751,908
Peter McGuire · National Human Genome Research Institute · ZIA · FY2012 · HG

Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2

$751,882
Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2024 · AI

Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal

$751,879
Jerome A. Zack · University Of California Los Angeles · R01 · FY2024 · AI

Microglia antigen presentation in the CNS of Alzheimer's disease

$751,861
Wassim Elyaman · Columbia University Health Sciences · R01 · FY2020 · AG